IP Library › Granted Patent US 12,414,810
Granted Patent B2
US 12,414,810 · App. 18/227,915 · Granted Sep 16, 2025

Surgical instruments and methods for performing tonsillectomy, adenoidectomy, and other surgical procedures

Inventors: Craig V. Krastins (Arvada, CO); James D. Allen, IV (Broomfield, CO); Jessica E.C. Olson (Frederick, CO); Jason G. Weihe (Longmont, CO); Purvish Soni (Longmont, CO)
Assignee: Covidien LP
A61B18/12A61B17/26A61B17/29A61B18/1445A61B18/1485A61B90/03A61B2017/00353A61B2017/00424A61B2017/00526A61B17/0218A61B2017/2912A61B2017/2919A61B2017/292A61B2017/2925A61B2017/2926A61B2017/2936A61B17/295A61B2017/320044A61B2018/00184A61B2018/00327A61B2018/00607A61B2018/0091A61B2018/00928A61B18/1447A61B2018/1455
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,810
App. No.
18/227,915
Granted
Sep 16, 2025
Kind
B2
Abstract

A surgical instrument includes a housing, a shaft extending therefrom, an end effector assembly supported by the shaft, a movable handle, and a drive assembly. The drive assembly includes a translatable drive member for actuating the end effector assembly, and a torsion spring including first and second legs. The first leg is configured to translate through the housing in response to movement of the movable handle relative to the housing. The second leg is configured to translate through the housing in cooperation with the first leg to move the drive member longitudinally when a force acting on the drive member is less than a threshold force, and to remain in fixed position, thereby tensioning the torsion spring and retaining the drive member in fixed position when the force acting on the drive member is equal to or exceeds the threshold force.

Claims (28)

1. An electrosurgical end effector assembly, comprising:

first and second jaw members configured to grasp tissue therebetween, the first jaw member including:

a jaw frame defining a proximal portion and a distal portion, the proximal portion of the jaw frame including first and second spaced-apart flanges defining aligned pivot apertures configured to receive a pivot pin to pivotably couple the first and second jaw members with one another and aligned cam slots configured to receive a cam pin to drive pivoting of the first jaw member relative to the second jaw member, the distal portion of the jaw frame defining an upright and a base, wherein the upright and the base are substantially perpendicular relative to one another;

an electrode configured to conduct energy to tissue, the electrode including a leg extending in substantially parallel orientation relative to the upright, the leg defining a plurality of apertures spaced-apart along at least a portion of a length of the leg; and

an insulative housing extending along the leg and through the plurality of apertures of the leg to secure the electrode relative to the insulative housing.

2. The electrosurgical end effector assembly according to claim 1 , wherein the first jaw member defines a tunnel extending longitudinally along a portion of the leg and wherein a lead wire extends through the tunnel and electrically connects with the leg.

3. The electrosurgical end effector assembly according to claim 1 , further comprising a clevis operably receiving the first and second spaced-apart flanges of the proximal portion of the jaw frame.

4. The electrosurgical end effector assembly according to claim 1 , wherein the first and second jaw members are configured to conduct electrosurgical energy through tissue grasped therebetween.

5. The electrosurgical end effector assembly according to claim 1 , wherein the electrode of the first jaw member and an electrode of the second jaw member are configured to conduct electrosurgical energy through tissue grasped therebetween.

6. The electrosurgical end effector assembly according to claim 1 , wherein the electrode includes an exposed portion that is exposed above the insulative housing.

7. The electrosurgical end effector assembly according to claim 6 , wherein the exposed portion of the electrode defines a tissue contacting surface.

8. The electrosurgical end effector assembly according to claim 1 , wherein the jaw frame is stainless steel.

9. The electrosurgical end effector assembly according to claim 1 , wherein the insulative housing is a first overmold.

10. The electrosurgical end effector assembly according to claim 9 , wherein the first jaw member further includes a second overmold.

11. An electrosurgical end effector assembly, comprising:

first and second jaw members configured to grasp tissue therebetween, the first jaw member including:

a jaw frame defining a proximal portion and a distal portion, the proximal portion of the jaw frame including first and second spaced-apart flanges defining aligned pivot apertures configured to receive a pivot pin to pivotably couple the first and second jaw members with one another and aligned cam slots configured to receive a cam pin to drive pivoting of the first jaw member relative to the second jaw member, the distal portion of the jaw frame defining an upright and a base, wherein the upright and the base are substantially perpendicular relative to one another;

an electrode configured to conduct energy to tissue, the electrode including a leg defining an upper end and a lower end, the leg extending in substantially parallel orientation relative to the upright, the leg defining a plurality of apertures spaced-apart along at least a portion of a length of the leg and disposed between the upper and lower ends of the leg, wherein the upper end of the leg is exposed; and

an insulative spacer capturing the lower end of the leg within the insulative spacer, the insulative spacer disposed on the jaw frame and positioned to electrically isolate the electrode from the jaw frame.

12. The electrosurgical end effector assembly according to claim 11 , wherein the insulative spacer defines a tunnel extending longitudinally along a portion of the leg and wherein a lead wire extends through the tunnel and electrically connects with the leg.

13. The electrosurgical end effector assembly according to claim 11 , wherein the first and second jaw members are configured to conduct electrosurgical energy through tissue grasped therebetween.

14. The electrosurgical end effector assembly according to claim 11 , wherein the electrode of the first jaw member and an electrode of the second jaw member are configured to conduct electrosurgical energy through tissue grasped therebetween.

15. The electrosurgical end effector assembly according to claim 11 , wherein the electrode includes an exposed portion that is exposed above the insulative spacer.

16. The electrosurgical end effector assembly according to claim 11 , wherein the upright and the base of the jaw frame define an interior angle side of the jaw frame and an exterior angle side of the jaw frame, and wherein the insulative spacer is at least partially disposed on the interior angle side of the jaw frame.

17. The electrosurgical end effector assembly according to claim 16 , further comprising an insulative housing disposed on the exterior angle side of the jaw frame.

18. The electrosurgical end effector assembly according to claim 11 , wherein the insulative spacer is a first overmold.

19. The electrosurgical end effector assembly according to claim 18 , wherein the first jaw member further includes a second overmold.

20. The electrosurgical end effector assembly according to claim 19 , wherein the second overmold is an insulative housing.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2023
From: KRASTINS, CRAIG V.; ALLEN, JAMES D., IV; OLSON, JESSICA E.C.; WEIHE, JASON G.; SONI, PURVISH
To: COVIDIEN LP
Reel/Frame 064428/0606 →
Continuity (4)
Continuation 17065033 · Oct 7, 2020
Continuation 15806679 · Nov 8, 2017
Continuation 14719422 · May 22, 2015
Related Publication 20230371999A1 · Nov 23, 2023
References Cited (107)
US 2377540A · Silva · 1945 [cited by applicant]
US 5445638A · Rydell et al. · 1995 [cited by applicant]
US 5458598A · Feinberg et al. · 1995 [cited by applicant]
US 5605272A · Witt et al. · 1997 [cited by applicant]
US 5674220A · Fox · 1997 [cited by examiner]
US 5683412A · Scarfone · 1997 [cited by applicant]
US 5735849A · Baden et al. · 1998 [cited by applicant]
US 5891142A · Eggers et al. · 1999 [cited by applicant]
US 5919206A · Gengler et al. · 1999 [cited by applicant]
US 5935126A · Riza · 1999 [cited by applicant]
US 6077287A · Taylor et al. · 2000 [cited by applicant]
US 6129740A · Michelson · 2000 [cited by applicant]
US 6322579B1 · Muller · 2001 [cited by applicant]
US 6334860B1 · Dorn · 2002 [cited by applicant]
US 6443968B1 · Holthaus et al. · 2002 [cited by applicant]
US 6506208B2 · Hunt et al. · 2003 [cited by applicant]
US 6706056B2 · Bacher · 2004 [cited by applicant]
US 6770072B1 · Truckai et al. · 2004 [cited by applicant]
US 6790217B2 · Schulze et al. · 2004 [cited by applicant]
US 6887240B1 · Lands et al. · 2005 [cited by applicant]
US 7052496B2 · Yamauchi · 2006 [cited by applicant]
US 7083618B2 · Couture et al. · 2006 [cited by applicant]
US 7090673B2 · Dycus et al. · 2006 [cited by applicant]
US 7118587B2 · Dycus et al. · 2006 [cited by applicant]
US 7147638B2 · Chapman et al. · 2006 [cited by applicant]
US 7150097B2 · Sremcich et al. · 2006 [cited by applicant]
US 7255697B2 · Dycus et al. · 2007 [cited by applicant]
US 7384420B2 · Dycus et al. · 2008 [cited by applicant]
US 7441685B1 · Boudreaux · 2008 [cited by applicant]
US 7491202B2 · Odom et al. · 2009 [cited by applicant]
US 7494501B2 · Ahlberg et al. · 2009 [cited by applicant]
US 7549988B2 · Eberl et al. · 2009 [cited by applicant]
US 7559940B2 · McGuire et al. · 2009 [cited by applicant]
US 7628791B2 · Garrison et al. · 2009 [cited by applicant]
US 7753909B2 · Chapman et al. · 2010 [cited by applicant]
US 7758608B2 · DiCesare et al. · 2010 [cited by applicant]
US 7766910B2 · Hixson et al. · 2010 [cited by applicant]
US 7877853B2 · Unger et al. · 2011 [cited by applicant]
US 7922953B2 · Guerra · 2011 [cited by applicant]
US 8241320B2 · Lyons et al. · 2012 [cited by applicant]
US 8246618B2 · Bucciaglia et al. · 2012 [cited by applicant]
US 8252021B2 · Boulnois et al. · 2012 [cited by applicant]
US 8256080B2 · Cunningham et al. · 2012 [cited by applicant]
US 8266783B2 · Brandt et al. · 2012 [cited by applicant]
US 8388646B2 · Chojin · 2013 [cited by applicant]
US 8394094B2 · Edwards et al. · 2013 [cited by applicant]
US 8409244B2 · Hinman et al. · 2013 [cited by applicant]
US 8545534B2 · Ahlberg et al. · 2013 [cited by applicant]
US 8551090B2 · Sutter et al. · 2013 [cited by applicant]
US 8728118B2 · Hinman et al. · 2014 [cited by applicant]
US 8734443B2 · Hixson et al. · 2014 [cited by applicant]
US 8740933B2 · Anderson · 2014 [cited by applicant]
US 8789741B2 · Baxter, III et al. · 2014 [cited by applicant]
US 8814856B2 · Elmouelhi et al. · 2014 [cited by applicant]
US 8858553B2 · Chojin · 2014 [cited by applicant]
US 8968311B2 · Allen, IV · 2015 [cited by examiner]
US 9795435B2 · Allen, IV · 2017 [cited by examiner]
US 9918779B2 · Krastins et al. · 2018 [cited by applicant]
US 9918781B2 · Krastins et al. · 2018 [cited by applicant]
US 10828084B2 · Krastins et al. · 2020 [cited by applicant]
US 11007003B2 · Allen, IV et al. · 2021 [cited by applicant]
US 11026710B2 · Stamm et al. · 2021 [cited by applicant]
US 11730532B2 · Krastins et al. · 2023 [cited by applicant]
US 20030055424A1 · Ciarrocca · 2003 [cited by applicant]
US 20040116924A1 · Dycus · 2004 [cited by examiner]
US 20050090837A1 · Sixto, Jr. · 2005 [cited by applicant]
US 20070074807A1 · Guerra · 2007 [cited by applicant]
US 20080015575A1 · Odom · 2008 [cited by examiner]
US 20100063525A1 · Beaupre et al. · 2010 [cited by applicant]
US 20110270251A1 · Horner et al. · 2011 [cited by applicant]
US 20120184990A1 · Twomey · 2012 [cited by applicant]
US 20120215215A1 · Reschke et al. · 2012 [cited by applicant]
US 20120215220A1 · Manzo et al. · 2012 [cited by applicant]
US 20130046306A1 · Evans · 2013 [cited by examiner]
US 20130296848A1 · Allen, IV et al. · 2013 [cited by applicant]
US 20130296922A1 · Allen, IV et al. · 2013 [cited by applicant]
US 20140025073A1 · Twomey et al. · 2014 [cited by applicant]
US 20140135805A1 · Windgassen et al. · 2014 [cited by applicant]
US 20140257285A1 · Moua · 2014 [cited by applicant]
US 20140316408A1 · Davison et al. · 2014 [cited by applicant]
US 20140336628A1 · McFarland · 2014 [cited by applicant]
US 20150201953A1 · Strobl et al. · 2015 [cited by applicant]
US 20160338718A1 · Allen, IV et al. · 2016 [cited by applicant]
US 20160338763A1 · Allen, IV et al. · 2016 [cited by applicant]
US 20210022790A1 · Krastins et al. · 2021 [cited by applicant]
AU 2004216575A1 · 2005 [cited by applicant]
CA 2844067A1 · 2014 [cited by applicant]
EP 2319447A1 · 2011 [cited by applicant]
EP 2777586A1 · 2014 [cited by applicant]
Partial European Search Report issued in corresponding European application No. 16170578.5 dated Sep. 1, 2016. [cited by applicant]
Extended European search report issued in corresponding application No. 16170578.5 dated Dec. 5, 2016. [cited by applicant]
Examination report issued in corresponding Australian application No. 2016203259 dated Jun. 2, 2017. [cited by applicant]
Canadian Office Action issued in corresponding CA application No. 2930309 dated Dec. 7, 2017. [cited by applicant]
European Search Report dated Jun. 27, 2018, corresponding to European Application No. 18167604.0; 7 pages. [cited by applicant]
Australian Examination Report dated Aug. 24, 2018, corresponding to counterpart Australian Application No. 2018201955; 2 pages. [cited by applicant]
Australian Examination Report dated May 16, 2019, corresponding to counterpart Australian Application No. 2019200661; 3 pages. [cited by applicant]
European Examination Report dated May 4, 2020, correspnding to counterpart European Application No. 18167804.0; 5 pages. [cited by applicant]
Canadian Office Action issued in corresponding Canadian Application No. 3,029,355 dated Apr. 11, 2023, 3 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 14/719,452, mailed on Feb. 25, 2019, 12 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 14/719,452, mailed on Nov. 6, 2017, 10 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 14/719,452, mailed on Oct. 22, 2019, 15 pages. [cited by applicant]
Non Final Office Action received for U.S. Appl. No. 14/719,434, mailed on Jun. 15, 2017, 7 pages. [cited by applicant]
Non Final Office Action received for U.S. Appl. No. 14/719,452, mailed on Jun. 11, 2019, 13 pages. [cited by applicant]
Non Final Office Action received for U.S. Appl. No. 17/065,033, mailed on Nov. 29, 2022, 10 pages. [cited by applicant]
Non Final Office Action received for U.S. Appl. No. 17/065,033, mailed on Sep. 30, 2022, 10 pages. [cited by applicant]
Notice of Allowance received for U.S. Appl. No. 14/719,464, mailed on Jun. 23, 2017, 9 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 17/065,010, mailed on Sep. 30, 2022, 12 pages. [cited by applicant]